JP2022513426A5 - - Google Patents

Info

Publication number
JP2022513426A5
JP2022513426A5 JP2021523074A JP2021523074A JP2022513426A5 JP 2022513426 A5 JP2022513426 A5 JP 2022513426A5 JP 2021523074 A JP2021523074 A JP 2021523074A JP 2021523074 A JP2021523074 A JP 2021523074A JP 2022513426 A5 JP2022513426 A5 JP 2022513426A5
Authority
JP
Japan
Prior art keywords
sequence
identity
copies
sequence shown
sequence number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021523074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513426A (ja
JP7590962B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/059927 external-priority patent/WO2020097121A1/en
Publication of JP2022513426A publication Critical patent/JP2022513426A/ja
Publication of JP2022513426A5 publication Critical patent/JP2022513426A5/ja
Priority to JP2024198841A priority Critical patent/JP7774695B2/ja
Application granted granted Critical
Publication of JP7590962B2 publication Critical patent/JP7590962B2/ja
Priority to JP2025175276A priority patent/JP2026021360A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021523074A 2018-11-05 2019-11-05 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 Active JP7590962B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024198841A JP7774695B2 (ja) 2018-11-05 2024-11-14 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
JP2025175276A JP2026021360A (ja) 2018-11-05 2025-10-17 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201862755988P 2018-11-05 2018-11-05
US62/755,988 2018-11-05
US201962806684P 2019-02-15 2019-02-15
US201962806600P 2019-02-15 2019-02-15
US62/806,684 2019-02-15
US62/806,600 2019-02-15
US201962872021P 2019-07-09 2019-07-09
US62/872,021 2019-07-09
PCT/US2019/059927 WO2020097121A1 (en) 2018-11-05 2019-11-05 Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024198841A Division JP7774695B2 (ja) 2018-11-05 2024-11-14 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Publications (3)

Publication Number Publication Date
JP2022513426A JP2022513426A (ja) 2022-02-08
JP2022513426A5 true JP2022513426A5 (enExample) 2022-11-10
JP7590962B2 JP7590962B2 (ja) 2024-11-27

Family

ID=70612483

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021523074A Active JP7590962B2 (ja) 2018-11-05 2019-11-05 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
JP2024198841A Active JP7774695B2 (ja) 2018-11-05 2024-11-14 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
JP2025175276A Pending JP2026021360A (ja) 2018-11-05 2025-10-17 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024198841A Active JP7774695B2 (ja) 2018-11-05 2024-11-14 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
JP2025175276A Pending JP2026021360A (ja) 2018-11-05 2025-10-17 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物

Country Status (6)

Country Link
US (2) US12703873B2 (enExample)
EP (1) EP3877529A4 (enExample)
JP (3) JP7590962B2 (enExample)
AU (2) AU2019375975B2 (enExample)
CA (1) CA3118689A1 (enExample)
WO (1) WO2020097121A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7590962B2 (ja) 2018-11-05 2024-11-27 アレン インスティテュート 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
CA3142948A1 (en) 2019-02-15 2020-08-20 Allen Institute Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations
CN113710693B (zh) 2019-02-25 2025-07-15 马萨诸塞大学 Dna结合结构域反式激活因子及其用途
WO2021248085A2 (en) * 2020-06-04 2021-12-09 Allen Institute Artificial expression constructs for selectively modulating gene expression in inhibitory neocortical neurons
EP4185303A4 (en) * 2020-07-24 2024-10-30 University of Massachusetts Dna-binding domain transactivators and uses thereof
US20230302158A1 (en) * 2020-08-14 2023-09-28 Allen Institute Artificial expression constructs for modulating gene expression in striatal neurons
GB202013940D0 (en) 2020-09-04 2020-10-21 Synpromics Ltd Regulatory nucleic acid sequences
EP4244366A4 (en) * 2020-11-10 2024-12-25 Allen Institute Artificial expression constructs for modulating gene expression in chandelier cells
EP4277524A4 (en) * 2021-01-13 2025-06-04 Duke University Compositions for and methods of improving fluid flux in the brain
US20240182923A1 (en) * 2021-03-30 2024-06-06 Allen Institute Artificial expression constructs for modulating gene expression in claustrum neurons
AU2022276538A1 (en) * 2021-05-21 2023-11-09 Allen Institute Artificial expression constructs for modulating gene expression in neurons within the thalamus
CN113736734B (zh) * 2021-09-23 2022-10-25 中山大学中山眼科中心 一种用于灵长类动物神经元分离的试剂盒及方法
WO2023108021A1 (en) * 2021-12-07 2023-06-15 Allen Institute Artificial expression constructs for modulating gene expression in neocortical layer 4 or layer 5 intratelencephalic neurons
AU2023226080A1 (en) * 2022-02-24 2024-10-03 Allen Institute Artificial expression constructs for modulating gene expression in dopaminergic neurons
CN114752624B (zh) * 2022-04-08 2025-04-15 中国海洋大学 一种侏儒蛤卵子的电穿孔方法
WO2024011224A2 (en) * 2022-07-08 2024-01-11 The Trustees Of Columbia University In The City Of New York Regulatory element for cell type specific expression of genes in spinal motor neurons
WO2024238448A2 (en) * 2023-05-12 2024-11-21 Temple University - Of The Commonwealth System Of Higher Education Chimeric capsid recombinant adeno-associated virus with bbb penetration and microglia targeting (aav-bm)
CN117346715B (zh) * 2023-12-04 2024-03-08 成都深瑞同华科技有限公司 一种配电网架空线路弧垂测定方法、系统及存储介质

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549910A (en) 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
JP3218637B2 (ja) 1990-07-26 2001-10-15 大正製薬株式会社 安定なリポソーム水懸濁液
JP2958076B2 (ja) 1990-08-27 1999-10-06 株式会社ビタミン研究所 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5738868A (en) 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
DE69918090T2 (de) 1998-04-24 2005-06-16 University Of Florida, Gainesville Rekombinanter adeno-assoziierter viraler vektor, der alpha-1 antitrypsin kodiert, zur gentherapie
US20070037165A1 (en) 2000-09-08 2007-02-15 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
EP1430114B1 (en) 2001-09-14 2012-01-18 Stem Cell Therapeutics Inc. Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
EP2028268A1 (en) * 2007-08-20 2009-02-25 Université Libre De Bruxelles Generation of neuronal cells from pluripotent stem cells
EP3702460A1 (en) 2010-11-12 2020-09-02 The General Hospital Corporation Polycomb-associated non-coding rnas
US20120308530A1 (en) 2011-06-03 2012-12-06 Beijing Allgens Medical Science & Technology Co., Ltd. Materials Composition and Methods to Control Neural Progenitor and Stem Cell Attachment, Proliferation and Guide Cell Differentiation
US9284575B2 (en) 2012-03-06 2016-03-15 Duke University Synthetic regulation of gene expression
WO2013155222A2 (en) 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
US9579399B2 (en) 2012-08-27 2017-02-28 Friedrich Miescher Institute For Biomedical Research Retinal OFF circuit-specific promoter
EP2922972B1 (en) * 2012-11-26 2017-04-26 Ecole Polytechnique Fédérale de Lausanne (EPFL) Colorectal cancer classification with differential prognosis and personalized therapeutic responses
US20150376612A1 (en) 2014-06-10 2015-12-31 The General Hospital Corporation CCCTC-Binding Factor (CTCF) RNA Interactome
CL2014003590A1 (es) * 2014-12-30 2015-07-10 Univ Chile Virus aav/xbp1s-ha, método de tratamiento genético y su uso en la optimizacion y mejoramiento de las capacidades cognitivas, de memoria y de aprendizaje.
US10682424B2 (en) 2015-03-31 2020-06-16 New York University Compositions and method for reducing seizures
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
AU2016366549B2 (en) 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
EP3416663B1 (en) 2016-02-18 2021-04-14 The Penn State Research Foundation Generating gabaergic neurons in brains
CN117821509A (zh) * 2017-04-03 2024-04-05 编码治疗公司 组织选择性转基因表达
JP7590962B2 (ja) 2018-11-05 2024-11-27 アレン インスティテュート 皮質興奮性ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
CA3142948A1 (en) 2019-02-15 2020-08-20 Allen Institute Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations

Similar Documents

Publication Publication Date Title
US20230310657A1 (en) Modified mglur6 promoter and methods of use
US12281321B2 (en) Frataxin expression constructs having engineered promoters and methods of use thereof
ES2945427T3 (es) Secuencias de AAV ancestrales y usos de las mismas
Zinn et al. In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector
JP2026021360A5 (enExample)
Colella et al. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients
Liu et al. Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector
AU2002352261B2 (en) A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
JP2021512649A5 (enExample)
RU2765826C2 (ru) Векторная система на основе аденоассоциированного вируса
JP2023515072A5 (enExample)
JP2025120285A5 (enExample)
JP2022106918A (ja) Rdh12が関与する疾患及び疾病を治療する方法及び組成物
JP2024513907A5 (enExample)
JP2018526994A5 (enExample)
Horowitz et al. Glycated AAV vectors: chemical redirection of viral tissue tropism
CN114848851A (zh) 治疗β-地中海贫血的药物
CN116218849B (zh) 针对utrophin激活治疗杜氏肌营养不良的sgRNA和应用
Xiong et al. Distinct expression patterns of AAV8 vectors with broadly active promoters from subretinal injections of neonatal mouse eyes at two different ages
JP2023535232A (ja) 眼疾患の処置のための組成物および方法
JP2018536432A5 (enExample)
JP2024525742A5 (enExample)
JP2020535203A5 (enExample)
CN119968387A (zh) 用于治疗癫痫的表达前强啡肽原变体的基因治疗载体
JP2024524270A5 (enExample)